Markets›Health care›DHR

Danaher

DHR
224.49
+0.72 (+0.32%)
Closing price for Sep 25, 2026 from Polygon.io
Income statement Balance sheet Cash flow | Annual Quarterly |Download CSV
Income statement (USD) Q2 2026
ended Jun 26, 2026
Q1 2026
ended Mar 27, 2026
Q4 2025
ended Dec 31, 2025
Q3 2025
ended Sep 26, 2025
Q2 2025
ended Jun 27, 2025
Q1 2025
ended Mar 28, 2025
Q4 2024
ended Dec 31, 2024
Q3 2024
ended Sep 27, 2024
Revenue 6.26B5.95B6.84B6.05B5.94B5.74B6.54B5.80B
Cost of revenue 2.65B2.36B2.87B2.53B2.41B2.23B2.65B2.40B
Gross profit 3.61B3.59B3.97B3.52B3.52B3.51B3.89B3.40B
Research and development 412.00M387.00M438.00M378.00M403.00M379.00M442.00M383.00M
Selling, general and admin 2.07B1.86B2.03B1.99B2.36B1.86B2.02B2.06B
Operating income 1.13B1.34B1.50B1.15B760.00M1.27B1.43B958.00M
EBITDA 1.32B1.54B1.70B1.34B945.00M1.46B1.61B1.14B
Interest expense 107.00M63.00M55.00M67.00M71.00M72.00M61.00M87.00M
Income before tax 1.08B1.24B1.37B1.08B655.00M1.13B1.31B977.00M
Income tax 208.00M206.00M190.00M168.00M100.00M175.00M229.00M159.00M
Net income 870.00M1.03B1.20B908.00M555.00M954.00M1.09B818.00M
EPS 1.231.451.691.280.771.331.501.13
EPS (diluted) 1.231.451.681.270.771.321.491.12
Diluted shares 707.60M711.20M-1.80M713.70M719.10M720.80M-2.90M729.40M

From Danaher's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.

Charts

Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.